Enteral feeding via a percutaneous endoscopic gastrostomy tube is required for nutritional support in patients with dysphagia. Enteral tube feeding bypasses the innate defence mechanisms in the upper gastrointestinal tract. This study examined the surface-associated microbial populations and immune response in the gastric and duodenal mucosae of eight enteral nutrition (EN) patients and ten controls. Real-time PCR and fluorescence in situ hybridization were employed to assess microbiota composition and mucosal pro-inflammatory cytokine expression. The results showed that EN patients had significantly higher levels of bacterial DNA in mucosal biopsies from the stomach and duodenum (P,0.05) than the controls, and that enterobacteria were the predominant colonizing species on mucosal surfaces in these individuals. Expression of the pro-inflammatory cytokines interleukin (IL)-1a, IL-6 and tumour necrosis factor-a was significantly higher in gastric and small intestinal mucosae from patients fed normal diets in comparison with those receiving EN (P,0.05). These results indicate that EN can lead to significant bacterial overgrowth on upper gastrointestinal tract mucosae and a significantly diminished pro-inflammatory cytokine response.
INTRODUCTION
Patients with dysphagia or impaired swallowing, which is most commonly due to neurological or oropharyngeal disease, require long-term nutritional support. Enteral nutrition (EN) is the preferred route because it is safer and more physiological than parenteral feeding as it preserves the barrier and absorptive functions of the gut. Enteral feeding is usually initiated in the hospital setting via a nasogastric tube, but when EN support is required long term, a percutaneous endoscopic gastrostomy (PEG) tube is inserted endoscopically.
The upper gastrointestinal tract is usually only sparsely colonized by bacteria and yeasts. In the healthy stomach, the numbers of viable bacterial cells are usually ,10 2 c.f.u. (ml stomach contents)
21
, with aciduric organisms such as lactobacilli and streptococci predominating and, in a subset of the normal healthy population, Helicobacter pylori (Simon & Gorbach, 1986; Marshall, 1994; .
There are many reasons to suppose that bacterial overgrowth in the proximal gut may be common in EN, as this procedure bypasses the innate defences that normally prevent extensive microbial colonization of the upper gut. The lack of sensory stimuli associated with normal food intake inhibits the production of saliva and peristalsis, whilst reduced swallowing increases intra-gastric pH and reduces gastric nitrite concentrations (O'May et al., 2005) . The use of a PEG tube acts as a conduit through which micro-organisms can migrate into the stomach. The net effect is greater susceptibility to microbial overgrowth in the stomach and duodenum, which commonly results in diarrhoea or more serious complications such as malabsorption and sepsis (Pearce & Duncan, 2002) .
Our knowledge of the effect of EN on the proximal gut microbiota is derived from bacteriological studies of fluid aspirates, employing traditional culture-based techniques (O'May et al., 2005) . Microbial colonization at the mucosal surface has not been studied previously in enteral-tubefeeding (ETF) patients, yet micro-organisms at this site exist in close juxtaposition to host tissues and communicate directly with gut-associated lymphoid tissue (GALT). In malnutrition associated with bacterial overgrowth, the gut barrier function is impaired, resulting in increased risk of microbial translocation (Welsh et al., 1998) . This disturbance in gut barrier function is associated with an increased risk of sepsis and the development of multi-organ failure (O'Boyle et al., 1998; MacFie et al., 1999) .
The aims of this investigation were to examine the surfaceassociated microbial populations in gastric and duodenal mucosae of patients receiving EN and to determine their effects on the mucosal immune system.
METHODS
Study groups. One hundred and eight patients undergoing PEG tube insertion or replacement at Ninewells Hospital, Dundee, UK, were assessed for inclusion in the study. Of these, 19 were found to be suitable and eight patients consented to take part in the study. Gastric and duodenal tissue samples were obtained from seven individuals, whilst the eighth had a total gastrectomy for ulcerative disease, and biopsies were collected from the jejunum. All ETF patients received enteral feeding for at least 2 weeks prior to endoscopic sampling, via either a nasogastric or a gastrostomy tube. Tissue samples were obtained from the stomachs and duodena of ten control subjects, who were healthy individuals not requiring nutritional support with normal upper gastrointestinal tracts on endoscopic examination. None of the controls had received antibiotics or antacid medication within 1 month of endoscopy. Approval for this research was obtained from the MultiCentre Research Ethics Committee for Scotland, Edinburgh, UK.
Endoscopic sample collection. Prior to use, all endoscopes (EVIS GIF-XK240 gastroscopes; KeyMed) underwent a full sterilization process (2 %, v/v, glutaraldehyde for 20 min), according to the manufacturer's instructions. The endoscopes underwent standard weekly sterility testing in the clinical microbiology laboratories at Ninewells Hospital. Tissue samples from the stomach and duodenum were collected using disposable forceps (Boston Scientific) inserted via the biopsy channel of the endoscope. Biopsies were suspended in sterile half-strength peptone water for transport to the laboratory and were processed within 1 h of collection. Tissue samples were transferred aseptically from peptone water to sterile Eppendorf tubes for storage at 280 uC.
Analysis of gastric and duodenal microbiotas. Bacterial DNA was extracted from gastric and duodenal biopsies using a DNeasy Tissue kit (Qiagen). Results from previous culture-based investigations directed the choice of bacteria-and yeast-specific primers for the detection of microbial groups and species predominating in the upper gastrointestinal tract aspirates of ETF patients (O'May et al., 2005) . Real-time PCR assays for quantification of Candida albicans, members of the genus Bifidobacterium and total enterobacteria were validated in a previous investigation in this laboratory (Bartosch et al., 2004) . Staphylococcus species primers were designed by altering the sequence of the forward primer from an S. aureusspecific primer pair (Paju et al., 2003) using Primer Premier software (Premier Biosoft International), so that the primer pair would detect all staphylococcus species. Primer specificities and optimum annealing temperatures were as described previously (Bartosch et al., 2004) .
Analysis of cytokines in tissue samples. The mucosal immune response to ETF was assessed by analysis of inflammatory cytokine expression in gastric and duodenal biopsies. These analyses involved measurement of the differential expression of genes in the upper gastrointestinal mucosa in response to ETF. This required amplification of RNA, which was then reverse-transcribed to cDNA to provide the necessary templates for PCR (Furrie et al., 2005) . The results for mucosal pro-inflammatory cytokine levels were normalized for total cells per biopsy using the housekeeping glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene.
Real-time PCR. This was carried out using an iCycler iQ with iCycler Optical System Interface Software (Bio-Rad). The primer sets used in the study are listed in Table 1 . Each reaction was carried out in duplicate in a volume of 20 ml, using 96-well optical-grade PCR plates. Each reaction contained 5 ml SYBR Green Mastermix (BioRad), 0.5 ml each forward and reverse primer, 3.2 ml PCR water and 1.7 ml DNA extract. The cycling parameters were: one cycle at 95 uC for 3 min, 35 cycles of denaturation at 95 uC for 30 s and primer annealing at the appropriate temperature (Table 1) for 30 s, followed by a final cycle at 95 uC for 30 s. Melt-curve analyses were carried out by slowly heating the PCRs from 55 to 95 uC (1 uC per cycle of 10 s) with simultaneous measurement of the SYBR Green signal intensity. Bacterial quantification and mucosal cytokine concentrations were determined by quantitative real-time PCR with plasmid DNA standards using methods developed previously in our laboratory (Bartosch et al., 2004; Furrie et al., 2005) . 
2003) GAAGAGCCCTCAGGCTGGACTG
Oligonucleotide probes. The 16S rRNA gene oligonucleotide probes used in this study have been described and validated previously. The universal bacterial probe Eub 338 (59-GCTGCCTCCCGTAGGAGT-39) was used for total bacteria (Amann et al., 1990) , Bif164 (59-CATC-CGGCATTACCACCC-39) for bifidobacteria (Langendijk et al., 1995) , Strc0493 (59-GTTAGCCGTCCCTTTCTGG-39) for streptococci (Franks et al., 1998) , Lacb0722 (59-YCACCGCTACACATGRAGTTCCACT-39) for lactic acid bacteria including lactobacilli (Sghir et al., 1998) , PF2 (59-CTCTGGCTTCACCCTATTC-39) for yeasts (Kempf et al., 2000) , Sta185 (59-TCCTCCATATCTCTGCGC-39) for staphylococci (Kempf et al., 2000) and Ent1 (59-CCGCTTGCTCTCGCGAG-39) for enterobacteria (Loge et al., 1999) . The probes were synthesized by Thermo Hybaid and 59-labelled with FITC or Cy3.
Fluorescence in situ hybridization (FISH). Hybridization for oligonucleotide probes was carried out in a humid chamber for 2 h and visualized using a Nikon Eclipse E800 upright microscope attached to a Nikon PCM 2000 confocal system with C-Imaging software (Compix) using methods described previously .
Statistics. Data analysis was carried out using GraphPad Prism version 4.0 (GraphPad Software). Logarithms of 16S rRNA gene copy numbers and means±SD were calculated. A non-parametric MannWhitney U test was used for comparison of the subject groups, and a P value .0.05 was considered to be statistically significant.
RESULTS

Patients
Biopsies were obtained from eight EN patients and ten controls. Their clinical details are shown in Tables 2 and 3 . The ETF patients had a mean age of 67.4 years and the commonest indication for EN was weight loss and malnutrition (four patients). At the time of endoscopy, three patients were receiving antacid therapy, five had received antibiotics and four had been given antifungal agents within 1 month of sample collection. The mean age of the control group was 66.5 years and the commonest indication for upper gastrointestinal endoscopy was dyspepsia (six patients).
Microbial analysis
Gastric and duodenal mucosal microbiotas were analysed by quantitative real-time PCR using genus-and species-specific primers. The results are expressed as mean log 10 gene copy number±SD (mg mucosal tissue) 21 (Table 4) . Tissue samples from the stomachs and duodena of healthy control subjects were sparsely colonized, with the highest count being log 10 1.21±0.36 gene copy numbers mg 21 for C. albicans in the duodenum. Counts for bacteria belonging to the genera Bifidobacterium and Staphylococcus were significantly higher in the stomach than in the duodenum in the control group, whilst enterobacteria were significantly higher in the duodenum (P,0.05). Mean counts of enterobacteria, bifidobacteria and staphylococci were significantly higher in gastric and duodenal biopsies from the EN group in comparison with controls (P,0.05) whilst there was no significant difference in counts between gastric and duodenal mucosae. C. albicans DNA was only detectable in a single gastric mucosal sample from the EN group with a log 10 gene copy number mg 21 value of 1.47.
FISH
FISH staining with the enterobacteria-specific probe showed the presence of enterobacterial microcolonies and single cells covering the surfaces of gastric and duodenal biopsies in the ETF patients. In all cases, these localized with the eubacterial probe for total bacteria and confirmed that enterobacteria were the predominant colonizing species on gut surfaces in these patients (Fig. 1) .
Cytokine analysis
Significant differences were observed for expression of the pro-inflammatory cytokines interleukin (IL)-1a, IL-6 and tumour necrosis factor-a (TNF-a) in the stomach (IL-1a, P,0.0002; IL-6, P,0.0012) and duodenum (IL-1a, P,0.0001; IL-6, P,0.0001; TNF-a, P50.0031) between EN and normal diets (Table 5) . One exception was TNF-a levels in the stomach, where no significant difference in expression was seen between EN and a normal diet (P50.2698). There was no significant difference in the level of pro-inflammatory cytokine expression in biopsies from the stomach and duodenum from either EN or normal feeding groups, with the exception of TNF-a and IL-1a in subjects with a normal diet. TNF-a and IL-1a expression was significantly higher in the duodenum (TNF-a, P50.0007; IL-1a, P50.0185) in individuals eating normally.
DISCUSSION
Enteral feeding bypasses innate defence mechanisms in the proximal gastrointestinal tract, resulting in microbial overgrowth. To our knowledge, this is the first investigation that has aimed to characterize microbial populations on mucosal surfaces in the upper gut in patients receiving EN, and to study the effects on the mucosal inflammatory response.
Previous investigations of gastric and duodenal microbiotas have involved culture-based work on aspirates (Giannella et al., 1972; O'May et al., 2005) or nonquantitative molecular-based analyses of tissue samples from patients with gastritis or colon cancer (Monstein et al., 2000; Dicksved et al., 2009) . This study employed quantitative real-time PCR to compare proximal gut mucosal populations in ETF patients with those in normal control subjects. Carriage of H. pylori was excluded in each volunteer by Campylobacter-like organism or serology testing.
Gastric and duodenal tissues from the controls were sparsely colonized by enterobacteria, bifidobacteria and staphylococci, with mean counts of ¡1.1 log 10 gene copies (mg tissue)
21
. The most prominent organism detected in the control population was C. albicans with 1.11±0.26 log 10 gene copies mg 21 in the stomach and 1.21±0.36 log 10 gene copies mg 21 in the duodenum (Table 4 ). C. albicans is an organism that is often detected in healthy individuals. However, when the body's defences are weakened, as in immunosuppressed people, it can act as an opportunistic pathogen. These findings are in concordance with earlier culture-based investigations of proximal gut aspirates (Marshall, 1999) , although in the control group in the present study, bifidobacterial and staphylococcal colonization was greater in the stomach than in the duodenum, whereas the previous work indicated that the duodenum had the more complex microbiota, with cell population densities of approximately 10 2 -10 4 c.f.u. ml 21 (Nord & Kager, 1984) .
Microbial colonization of gastric and duodenal mucosae was significantly higher in ETF patients than in controls.
The exception was C. albicans, which was detected only in a single gastric biopsy sample. Previous studies of EN patients reported significant overgrowth of Candida (.10 4 c.f.u. ml
) in aspirates taken from the proximal gut (O'May et al., 2005) , and it is likely that the use of antifungal medication in this patient group (50 % of subjects) had confounding effects with respect to yeast colonization. However, the bacteriological data showed similar results to previous investigations, with significantly higher numbers of enterobacteria, bifidobacteria and staphylococci in the ETF group. There was no significant difference in counts between gastric and duodenal mucosal populations, which agrees with previous culture-based analyses, which also reported a loss of compositional distinction between gastric and duodenal microbiotas in response to EN (O'May et al., 2005) .
In the ETF group, the predominant organisms on the mucosal surfaces were enterobacteria and staphylococci. Enterobacterial DNA levels exceeded those of staphylococci, with 16S rRNA gene copy numbers of 5.01±2.62 log 10 gene copies mg 21 in the gastric mucosa and 5.41±2.59 log 10 gene copies mg 21 in the duodenum, compared with 2.20±0.19 and 1.83±0.35 log 10 gene copies mg
, respectively. Fluorescence microscopy using a range of probes including those for aciduric bacteria such as streptococci and lactobacilli, which have been shown previously to be found in the upper gastrointestinal tract of healthy individuals (Savage, 1977; Simon & Gorbach, 1986) , confirmed that enterobacteria were the prevalent colonizing species on the proximal gut mucosa of the ETF patients. Bacteria at the mucosal surface grow in close proximity to the gut-associated immune system and are thought to play an important role in gut barrier function. The association of EN with overgrowth of potential pathogens at the mucosal surface may have significant sequelae for the immunocompromised patient, increasing the risk of translocation and systemic sepsis (Welsh et al., 1998) .
Fasting and malnutrition cause villous atrophy and increased mucosal permeability, whilst GALT diminishes in functionality (Welsh et al., 1998; Lin & Cohen, 2005) . The mucosal barrier becomes disorganized, and the reduction in lymphoid tissue makes it difficult for the body to mount appropriate immune response to pathogens (McKay & Baird, 1999) . In vitro studies of intestinal epithelial permeability have shown that raised concentrations of TNF-a increase intestinal permeability, whilst the anti-inflammatory cytokines IL-10 and transforming growth factor-b2 reverse this degeneration in barrier function (McKay & Baird, 1999) . Animal studies have also demonstrated that the absence of EN has a detrimental effect on GALT, resulting in reduced immunocompetent cellular activity and disrupted intestinal IgA production. However, GALT function is rapidly restored by administration of nutrients through the enteral route (Li et al., 1995; Heel et al., 1998) .
Measurements of pro-inflammatory cytokine expression in the upper gastrointestinal tract demonstrated a significantly diminished mucosal pro-inflammatory response to EN. Interestingly, this occurred in association with increased bacterial overgrowth and, most importantly, increased colonization by potential pathogens. However, the possession of virulence determinants was not established in this study. Taking into consideration previous findings, we would have expected to find increased activation of the intestinal immune system in response to bacterial overgrowth and artificial nutritional support. However, previous clinical studies have involved malnourished patients in the surgical or intensive care setting. None have investigated chronically malnourished patients requiring long-term nutritional support, and it is possible that the pro-inflammatory effects of malnutrition on GALT may diminish with time.
The processes that result in diminished production of pro-inflammatory cytokines are unclear, but possible mechanisms include reduced immune cellular activity and downregulation of the pro-inflammatory response, following prolonged exposure to pathogens. Potential clinical sequelae of a diminished mucosal immune response in the presence of microbial overgrowth involve complications associated with microbial translocation. The 'gut origin of sepsis' hypothesis proposes that bacteria normally resident in the gastrointestinal tract translocate across the intestinal epithelial barrier into the systemic circulation and act as a source of sepsis at distant sites (MacFie et al., 1999) . A reduction in the mucosal pro-inflammatory response can result in increased translocation of bacteria into the systemic circulation. Gut pathogens may cause sepsis at distant sites, or trigger the systemic immune system to produce the cytokine storm associated with multi-organ failure.
The small sample size was a limitation of this study. Tissue samples were obtained only once from the ETF patients, as multiple sampling is not recommended in this frail population and repeated endoscopy is associated with increased morbidity. A more comprehensive investigation of bacterial colonization and the mucosal immune response to EN is required, including analyses of antiinflammatory cytokine expression and IgA production.
Comparisons of EN patients with both healthy controls and patients on long-term parenteral nutrition are needed. Further studies into the effects of EN on microbial colonization and GALT function should indicate how the composition of enteral feeds can be modified to enhance their restorative effects on the gut barrier.
